Microdevice for Trapping Circulating Tumor Cells for Cancer Diagnostics

  • S. J. Tan
  • L. Yobas
  • G. Y. H. Lee
  • C. N. Ong
  • C. T. Lim
Part of the IFMBE Proceedings book series (IFMBE, volume 23)


Cancer metastasis is the main attribute to cancerrelated deaths and early detection is one of the most effective means to treat the disease. Spreading of cancer to distant sites is achieved usually through the circulatory system and the number of circulating tumor cells (CTCs) in peripheral blood is strongly associated to cancer development. Thus detecting CTCs in blood samples will be helpful in identifying susceptible subjects. Here, we propose a label-free technique to isolate these cancerous cells from blood. Using cancer cells spiked in blood samples, isolation efficiency of at least 80% were obtained with high isolation purity. The microdevice also preserved the integrity of the isolated cells to allow further studies to be done on these cells. These results showed a potential effective microdevice for CTCs studies and possible clinical application.


Cell Isolation Microfluidics Circulating Tumor Cells Cancer Metastasis Computational Fluid Dynamics (CFD) 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chambers A F, Groom A C and MacDonald I C (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572CrossRefGoogle Scholar
  2. 2.
    Lee G Y H and Lim C T (2007) Biomechanics approaches to studying human diseases. Trends Biotechnol 25:111–118CrossRefGoogle Scholar
  3. 3.
    Steeg P S (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895–904CrossRefGoogle Scholar
  4. 4.
    Heyder C, Gloria-Maercker E, Hatzmann W, et al. (2006) Visualization of tumor cell extravasation. Contrib Microbiol 13:200–208CrossRefGoogle Scholar
  5. 5.
    Cristofanilli M, Budd G T, Ellis M J, et al. (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781–791CrossRefGoogle Scholar
  6. 6.
    Reuben J M, Krishnamurthy S, Woodward W, et al. (2008) The role of circulating tumor cells in breast cancer diagnosis and prediction of therapy response. Expert Opinion on Medical Diagnostics 2:339–348CrossRefGoogle Scholar
  7. 7.
    Balic M, Dandachi N, Hofmann G, et al. (2005) Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry B Clin Cytom 68:25–30Google Scholar
  8. 8.
    Cristofanilli M, Broglio K R, Guarneri V, et al. (2007) Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer 7:471–479CrossRefGoogle Scholar
  9. 9.
    Lara O, Tong X, Zborowski M, et al. (2004) Enrichment of rare cancer cells through depletion of normal cells using density and flowthrough, immunomagnetic cell separation. Exp Hematol 32:891–904CrossRefGoogle Scholar
  10. 10.
    Pantel K, Brakenhoff R H and Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8:329–340CrossRefGoogle Scholar
  11. 11.
    Shelby J P, White J, Ganesan K, et al. (2003) A microfluidic model for single-cell capillary obstruction by Plasmodium falciparuminfected erythrocytes. 100:14618–14622Google Scholar
  12. 12.
    Mohamed H, McCurdy L D, Szarowski D H, et al. (2004) Development of a rare cell fractionation device: application for cancer detection. IEEE Trans Nanobioscience 3:251–256CrossRefGoogle Scholar
  13. 13.
    Weiss L (1990) Metastatic inefficiency. Adv Cancer Res 54:159–211CrossRefGoogle Scholar
  14. 14.
    Weiss L and Dimitrov D S (1986) Mechanical aspects of the lungs as cancer cell-killing organs during hematogenous metastasis. J Theor Biol 121:307–321CrossRefGoogle Scholar
  15. 15.
    Tan S J, Yobas L, Lee G Y H, et al. (2008) Microdevice for Isolating Viable Circulating Tumor Cells, International Conference on Biocomputation, Bioinformatics, and Biomedical Technologies, 2008. BIOTECHNO’ 08., Bucharest, Romania, 2008, pp. 109–113Google Scholar
  16. 16.
    McDonald J C, Duffy D C, Anderson J R, et al. (2000) Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis 21:27–40CrossRefGoogle Scholar
  17. 17.
    Urtishak S, Alpaugh R K, Weiner L M, et al. (2008) Clinical utility of circulating tumor cells: a role for monitoring response to therapy and drug development. Biomarkers in Medicine 2:137–145CrossRefGoogle Scholar
  18. 18.
    Dawood S, Broglio K, Valero V, et al. (2008) Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer Google Scholar
  19. 19.
    Allard W J, Matera J, Miller M C, et al. (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10:6897–6904CrossRefGoogle Scholar
  20. 20.
    Nagrath S, Sequist L V, Maheswaran S, et al. (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450:1235–1239CrossRefGoogle Scholar
  21. 21.
    Went P T, Lugli A, Meier S, et al. (2004) Frequent EpCam protein expression in human carcinomas. Hum Pathol 35:122–128CrossRefGoogle Scholar

Copyright information

© International Federation of Medical and Biological Engineering 2009

Authors and Affiliations

  • S. J. Tan
    • 1
    • 2
  • L. Yobas
    • 1
  • G. Y. H. Lee
    • 3
  • C. N. Ong
    • 4
  • C. T. Lim
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
  1. 1.A*STARInstitute of MicroelectronicsSingapore
  2. 2.NUS Graduate School for Integrative Sciences and EngineeringNational University of SingaporeSingapore
  3. 3.Singapore-MIT AllianceSingapore
  4. 4.Life Sciences InstituteNational University of SingaporeSingapore
  5. 5.Department of Mechanical EngineeringNational University of SingaporeSingapore
  6. 6.NanoBiomechanics Laboratory, Division of BioengineeringNational University of SingaporeSingaporeSingapore

Personalised recommendations